T-cell lymphoma cells carrying the oncogenic nucleophosmin/anaplastic lymphoma kinase (NPM/ALK), which is involved in malignant transformation, induce high levels of PD-L1 expression via STAT3 and ERK activation [18,19]. The gene discussed is CD274; the disease is T-cell non-Hodgkin lymphoma.